Upper gastrointestinal series

From WikiMD's WELLNESSPEDIA


The Upper Gastrointestinal Series (UH-per GAS-troh-in-TES-tih-nul SEER-eez), often referred to as the upper GI series, is a diagnostic imaging procedure that involves capturing a series of x-ray pictures of the esophagus, stomach, and duodenum (the initial segment of the small intestine).

An x-ray image from an Upper Gastrointestinal Series.

Procedure[edit]

During the test, the patient is required to consume a liquid solution that contains barium sulfate. This compound is a derivative of the silver-white metallic element, barium. After ingestion, the barium sulfate functions as a contrast medium, effectively coating the internal lining of the upper gastrointestinal tract. This coating enhances the visibility of the tract's inner walls on the x-ray images, allowing potential abnormalities or issues to be identified with greater clarity.

Purpose[edit]

The Upper Gastrointestinal Series is utilized to:

  • Diagnose abnormalities or diseases in the upper gastrointestinal tract.
  • Investigate symptoms like persistent abdominal pain, nausea, vomiting, or difficulty swallowing.
  • Examine conditions such as ulcers, tumors, or inflammation in the esophagus, stomach, or duodenum.

Risks and Considerations[edit]

While the procedure is generally considered safe, there may be minor side effects related to the consumption of the barium sulfate solution, including constipation or white-colored stools. Patients are advised to increase fluid intake post-procedure to help expel the barium from the system.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.